Metabolomics unveils disrupted pathways in Parkinson's disease: towards biomarker-based diagnosis
Ontology highlight
ABSTRACT: Traditional clinical observation methods often result in misdiagnosis, highlighting the need for biomarker-based diagnostic approaches. This study utilizes UPLC-ESI-QTOF untargeted metabolomics combined with biochemometrics to identify novel serum biomarkers for PD. Analyzing a Brazilian cohort of serum samples from 39 PD patients and 15 healthy controls, we identified fifteen metabolites significantly associated with PD
INSTRUMENT(S): Xevo G2-S QTof
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Albert Katchborian Neto
PROVIDER: MSV000095323 | MassIVE | Sat Jul 13 05:44:00 BST 2024
REPOSITORIES: MassIVE
ACCESS DATA